These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 18577180

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans.
    Flowers SA, Barker KS, Berkow EL, Toner G, Chadwick SG, Gygax SE, Morschhäuser J, Rogers PD.
    Eukaryot Cell; 2012 Oct; 11(10):1289-99. PubMed ID: 22923048
    [Abstract] [Full Text] [Related]

  • 23. Transcriptional regulation of MDR1, encoding a drug efflux determinant, in fluconazole-resistant Candida albicans strains through an Mcm1p binding site.
    Riggle PJ, Kumamoto CA.
    Eukaryot Cell; 2006 Dec; 5(12):1957-68. PubMed ID: 17041190
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans.
    Sasse C, Dunkel N, Schäfer T, Schneider S, Dierolf F, Ohlsen K, Morschhäuser J.
    Mol Microbiol; 2012 Nov; 86(3):539-56. PubMed ID: 22924823
    [Abstract] [Full Text] [Related]

  • 26. Multidrug-resistant transporter mdr1p-mediated uptake of a novel antifungal compound.
    Sun N, Li D, Fonzi W, Li X, Zhang L, Calderone R.
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5931-9. PubMed ID: 24041896
    [Abstract] [Full Text] [Related]

  • 27. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.
    Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhäuser J, Rogers PD.
    Eukaryot Cell; 2008 Jul; 7(7):1180-90. PubMed ID: 18487346
    [Abstract] [Full Text] [Related]

  • 28. Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains.
    Popp C, Hampe IAI, Hertlein T, Ohlsen K, Rogers PD, Morschhäuser J.
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461316
    [Abstract] [Full Text] [Related]

  • 29. Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans.
    Wang Y, Liu JY, Shi C, Li WJ, Zhao Y, Yan L, Xiang MJ.
    Int J Antimicrob Agents; 2015 Nov; 46(5):552-9. PubMed ID: 26404130
    [Abstract] [Full Text] [Related]

  • 30. Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl.
    Biermann AR, Hogan DA.
    mSphere; 2022 Jun 29; 7(3):e0012422. PubMed ID: 35473297
    [Abstract] [Full Text] [Related]

  • 31. Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence.
    Lohberger A, Coste AT, Sanglard D.
    Eukaryot Cell; 2014 Jan 29; 13(1):127-42. PubMed ID: 24243794
    [Abstract] [Full Text] [Related]

  • 32. A Hyperactive Form of the Zinc Cluster Transcription Factor Stb5 Causes YOR1 Overexpression and Beauvericin Resistance in Candida albicans.
    Ramírez-Zavala B, Manz H, Englert F, Rogers PD, Morschhäuser J.
    Antimicrob Agents Chemother; 2018 Dec 29; 62(12):. PubMed ID: 30249688
    [Abstract] [Full Text] [Related]

  • 33. Upc2-mediated mechanisms of azole resistance in Candida auris.
    Li J, Aubry L, Brandalise D, Coste AT, Sanglard D, Lamoth F.
    Microbiol Spectr; 2024 Feb 06; 12(2):e0352623. PubMed ID: 38206035
    [Abstract] [Full Text] [Related]

  • 34. Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans.
    Hiller D, Sanglard D, Morschhäuser J.
    Antimicrob Agents Chemother; 2006 Apr 06; 50(4):1365-71. PubMed ID: 16569853
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J.
    Antimicrob Agents Chemother; 1995 Nov 06; 39(11):2378-86. PubMed ID: 8585712
    [Abstract] [Full Text] [Related]

  • 38. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B, Teymuri M, Mahmoudi S, Valian SK, Movahedi Z, Eshaghi H, Mamishi S.
    Infect Disord Drug Targets; 2017 Nov 06; 17(3):178-184. PubMed ID: 28558643
    [Abstract] [Full Text] [Related]

  • 39. Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans.
    Morio F, Pagniez F, Besse M, Gay-andrieu F, Miegeville M, Le Pape P.
    Int J Antimicrob Agents; 2013 Nov 06; 42(5):410-5. PubMed ID: 24051054
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.